colorimetric in situ hybridization

(redirected from Chromogenic in Situ Hybridization)
Also found in: Acronyms.

colorimetric in situ hybridization

automated paraffin-based method used to detect plasma-cell and B-cell immunoglobulin light-chain restriction in bone marrow biopsies, among others. Also analogous to fluorescence in situ hybridization for detection of HER-2 gene amplification.
References in periodicals archive ?
Caris Molecular Intelligence(TM) utilizes the most comprehensive range of analytical technologies endorsed by the latest and most robust evidence - immunohistochemistries, fluorescence and chromogenic in situ hybridization, polymerase chain reaction and Next-Generation sequencing - to provide oncologists the most complete and clinically relevant profile of a patient's unique cancer-related biomarkers.
Chromogenic in situ hybridization uses chromogens for signal identification by means of indirect labeling.
The company's products and services are based on its proprietary RNAscope technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single-molecule sensitivity.
The company's products and services are based on its proprietary RNAscope(TM) technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.
the leading provider of automated cell-imaging systems and manufacturer of the ACIS(R) digital microscope system, announced that data presented at the 26th Annual San Antonio Breast Cancer Symposium showed that a new ACIS test called ACIS-assisted chromogenic in situ hybridization (ACIS-CISH), which can assist physicians in determining how to treat cancer patients, was found to be accurate, cost effective, and labor- saving as compared to fluorescence in situ hybridization, or FISH, a widely used competitive technology.